Ronan Levy: The Future of Mental Health

Today on the pod we’re very fortunate to host the Co-Founder and Executive Chairman of a company doing big things to advance the conversation around psychedelics and what it means to live a meaningful, healthy, integrated and thoughtful life

Everybody please give a warm welcome to Ronan Levy of Field Trip Health

Ronan and Field Trip have been on my radar since day one of this podcast as someone we hoped to engage in discourse with, and we made it happen 

On today’s pod we’re going to dive into the psychedelic finance end of the mycopreneurial spectrum, we’ll be using some big words like submarine patent, which I totally didn’t have to google what those mean during our conversation, we’re also going to unpack what the FDA approval process looks like in the context of psilocybin and synthetic derivatives thereof, we’ll look at the FT-104 novel molecule that Field Trip is currently developing and readying for the global market, 

and we’ll touch upon the existing dialogues and relationships between psychedelics companies and pharmaceutical companies on the world stage, and how psychedelic companies and mycopreneurs and the world at large could potentially benefit from leveraging the existing infrastructure built by pharmaceutical companies to scale psychedelic medicines and therapies to reach more people around the world 

I’ve fucking pumped that this little podcast that could is hosting world class disruptors like Ronan side by side with women mycopreneurs in Uganda and people living in the hills of Jamaica, so many more folks around the world leveraging the power of fungi to solve problems big and small, and to create healthier, happier lives of prosperity and abundance 

Hosted on Acast. See acast.com/privacy for more information.